AKT1 and cancer: This same phytochemical has also shown an interesting activity on metastatic MDA-MB-231 cells, as it inhibited both Akt/mTOR and NF-κB pathways, thus acting as a promising dual inhibitor of one of the major oncogenic driver pathways in many cancers [59].